Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate
2006-02-08
2009-10-06
Tsang, Cecilia (Department: 1654)
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
C424S085500, C424S085600, C424S085700, C530S350000, C530S351000
Reexamination Certificate
active
07597884
ABSTRACT:
The present invention provides synthetic Type I interferon receptor polypeptide agonists comprising consensus or hybrid Type I interferon receptor polypeptide agonists, containing one or more native or non-native glycosylation sites. The present invention provides synthetic Type I interferon receptor polypeptide agonists comprising consensus or hybrid Type I interferon receptor polypeptide agonists, containing one or more native or non-native glycosylation sites, as well as erythropoietin and darbepoetin alfa, each of which are linked to a penetrating peptide that facilitates translocation of a substance across a biological barrier as well as pharmaceutical compositions, including oral formulations, of the same. The present invention further provides oral formulations of hyperglycosylated or protease-resistant, hyperglycosylated polypeptide variants, which polypeptide variants lack at least one protease cleavage site found in a parent polypeptide, and thus exhibit increased protease resistance compared to the parent polypeptide, which polypeptide variants further include (1) a carbohydrate moiety covalently linked to at least one non-native glycosylation site not found in the parent protein therapeutic or (2) a carbohydrate moiety covalently linked to at least one native glycosylation site found but not glycosylated in the parent protein therapeutic. The present invention further provides compositions, including oral pharmaceutical compositions, comprising the synthetic Type I interferon receptor polypeptide agonist, the hyperglycosylated polypeptide variant, or the hyperglycosylated, protease-resistant polypeptide variant. The present invention further provides containers, devices, and kits comprising the synthetic Type I interferon receptor polypeptide agonist, the hyperglycosylated polypeptide variant, or the hyperglycosylated, protease-resistant polypeptide variant. The present invention further provides therapeutic methods involving administering an effective amount of an oral pharmaceutical composition comprising a synthetic Type I interferon receptor polypeptide agonist, a hyperglycosylated polypeptide variant, or a hyperglycosylated, protease-resistant polypeptide variant to an individual in need thereof.
REFERENCES:
patent: 3645090 (1972-02-01), Mochizuki et al.
patent: 3720760 (1973-03-01), Bennich et al.
patent: 3839346 (1974-10-01), Gadekar
patent: 3940475 (1976-02-01), Gross
patent: 3974281 (1976-08-01), Gadekar
patent: 4052509 (1977-10-01), Gadekar
patent: 4211771 (1980-07-01), Witkowski et al.
patent: RE30985 (1982-06-01), Cartaya
patent: 4560655 (1985-12-01), Baker
patent: 4657866 (1987-04-01), Kumar
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4695623 (1987-09-01), Stabinsky
patent: 4737456 (1988-04-01), Weng et al.
patent: 4767704 (1988-08-01), Cleveland et al.
patent: 4810643 (1989-03-01), Souza
patent: 4810804 (1989-03-01), Chandraratna
patent: 4877729 (1989-10-01), Clark et al.
patent: 4897471 (1990-01-01), Stabinsky
patent: 4927762 (1990-05-01), Darfler
patent: 4959455 (1990-09-01), Clark et al.
patent: 5041376 (1991-08-01), Gething et al.
patent: 5122469 (1992-06-01), Mather et al.
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5200534 (1993-04-01), Rao
patent: 5202448 (1993-04-01), Carver et al.
patent: 5229529 (1993-07-01), Ueno et al.
patent: 5240848 (1993-08-01), Keck et al.
patent: 5274137 (1993-12-01), Nicolaou et al.
patent: 5279949 (1994-01-01), Nair
patent: 5283253 (1994-02-01), Holton et al.
patent: 5294637 (1994-03-01), Chen et al.
patent: 5310562 (1994-05-01), Margolin
patent: 5332671 (1994-07-01), Ferrara et al.
patent: 5338840 (1994-08-01), Bayne et al.
patent: 5395760 (1995-03-01), Smith et al.
patent: 5415869 (1995-05-01), Straubinger et al.
patent: 5426098 (1995-06-01), Carlino
patent: 5462925 (1995-10-01), Ogawa et al.
patent: 5466861 (1995-11-01), Dawson et al.
patent: 5474978 (1995-12-01), Bakaysa et al.
patent: 5484720 (1996-01-01), Wurm et al.
patent: 5504188 (1996-04-01), Baker et al.
patent: 5514646 (1996-05-01), Chance et al.
patent: 5518729 (1996-05-01), Margolin
patent: 5520911 (1996-05-01), Anderson et al.
patent: 5521184 (1996-05-01), Zimmermann
patent: 5532343 (1996-07-01), Bayne et al.
patent: 5547929 (1996-08-01), Anderson, Jr. et al.
patent: 5559101 (1996-09-01), Weis et al.
patent: 5571714 (1996-11-01), Dasch et al.
patent: 5593875 (1997-01-01), Wurm et al.
patent: 5605690 (1997-02-01), Jacobs et al.
patent: 5631015 (1997-05-01), Bezwada et al.
patent: 5643575 (1997-07-01), Martinez et al.
patent: 5650486 (1997-07-01), De Felippis
patent: 5672662 (1997-09-01), Harris et al.
patent: 5674843 (1997-10-01), Carlino
patent: 5688666 (1997-11-01), Bass et al.
patent: 5688679 (1997-11-01), Powell
patent: 5690925 (1997-11-01), Gray et al.
patent: 5693609 (1997-12-01), Baker et al.
patent: 5700862 (1997-12-01), Chance et al.
patent: 5712113 (1998-01-01), Chung et al.
patent: 5716632 (1998-02-01), Margolin
patent: 5726152 (1998-03-01), Bayne et al.
patent: 5728074 (1998-03-01), Castellano et al.
patent: 5728377 (1998-03-01), Sarris et al.
patent: 5736371 (1998-04-01), Samain et al.
patent: 5747642 (1998-05-01), De Felippis
patent: 5759807 (1998-06-01), Breece et al.
patent: 5770378 (1998-06-01), Hwang et al.
patent: 5770382 (1998-06-01), Hwang et al.
patent: 5770383 (1998-06-01), Hwang et al.
patent: 5780676 (1998-07-01), Boehm et al.
patent: 5783185 (1998-07-01), Dasch et al.
patent: 5811395 (1998-09-01), Schwabe et al.
patent: 5821263 (1998-10-01), Scola et al.
patent: 5824685 (1998-10-01), Campochiaro et al.
patent: 5824701 (1998-10-01), Greenwald et al.
patent: 5853724 (1998-12-01), Garrity et al.
patent: 5869680 (1999-02-01), Mas et al.
patent: 5889144 (1999-03-01), Alila et al.
patent: 5922675 (1999-07-01), Baker et al.
patent: 5935567 (1999-08-01), Leder et al.
patent: 5945402 (1999-08-01), Cipolla et al.
patent: 5952297 (1999-09-01), De Felippis et al.
patent: 5965697 (1999-10-01), Czaplewski et al.
patent: 5985265 (1999-11-01), Kinstler et al.
patent: 6022711 (2000-02-01), Cunningham et al.
patent: 6034054 (2000-03-01), DeFelippis et al.
patent: 6046305 (2000-04-01), Choi
patent: 6057428 (2000-05-01), Keyt et al.
patent: 6090822 (2000-07-01), Margolin
patent: 6096010 (2000-08-01), Walters et al.
patent: 6100071 (2000-08-01), Davis-Smyth et al.
patent: 6127332 (2000-10-01), Goelz et al.
patent: 6132970 (2000-10-01), Stemmer
patent: 6136563 (2000-10-01), Cunningham et al.
patent: 6143523 (2000-11-01), Cunningham et al.
patent: 6143715 (2000-11-01), Llinas-Brunet et al.
patent: 6146361 (2000-11-01), DiBiasi et al.
patent: 6153600 (2000-11-01), Leder et al.
patent: 6168784 (2001-01-01), Offord et al.
patent: 6187330 (2001-02-01), Wang et al.
patent: 6200953 (2001-03-01), Schwabe et al.
patent: 6211144 (2001-04-01), Havelund
patent: 6214542 (2001-04-01), Striker et al.
patent: 6214854 (2001-04-01), Wang et al.
patent: 6221053 (2001-04-01), Walters et al.
patent: 6248095 (2001-06-01), Giambattista et al.
patent: 6265380 (2001-07-01), Tung et al.
patent: 6277830 (2001-08-01), Ganguly et al.
patent: 6288089 (2001-09-01), Zawada et al.
patent: 6296842 (2001-10-01), Jaworowicz et al.
patent: 6299877 (2001-10-01), Chen et al.
patent: 6300475 (2001-10-01), Chen et al.
patent: 6303148 (2001-10-01), Hennink et al.
patent: 6319921 (2001-11-01), Cirillo et al.
patent: 6323180 (2001-11-01), Llinas-Brunet et al.
patent: 6329379 (2001-12-01), Llinas-Brunet et al.
patent: 6329417 (2001-12-01), Llinas-Brunet et al.
patent: 6346269 (2002-02-01), Hsiao et al.
patent: 6348444 (2002-02-01), Chappel
patent: 6365157 (2002-04-01), Rockwell et al.
patent: 6375929 (2002-04-01), Thomas, Jr. et al.
patent: 6379701 (2002-04-01), Tracy et al.
patent: 6383486 (2002-05-01), Davis-Smyth et al.
patent: 6387879 (2002-05-01), Blume et al.
patent: 6410531 (2002-06-01), Llinas-Brunet et al.
patent: 6420380 (2002-07-01), Llinas-Brunet et al.
patent: 6423695 (2002-07-01), Tam et al.
patent: 6432962 (2002-08-01), Horneman
patent: 6440985 (2002-08-01), Bailey et al.
patent: 6448077 (2002-09-01), Rockwell et al.
patent
Blatt Lawrence M.
Hong Jin
Seiwert Scott D.
Alios BioPharma, Inc.
Ha Julie
Knobbe Martens Olson & Bear LLP
Tsang Cecilia
LandOfFree
Hyperglycosylated polypeptide variants and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hyperglycosylated polypeptide variants and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hyperglycosylated polypeptide variants and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4061782